Sunitinib-induced thyrotoxicosis - a not so rare entity. 2015

Marijana Jazvić, and Marin Prpić, and Tomislav Jukić, and Jure Murgić, and Blanka Jakšić, and Davor Kust, and Angela Prgomet, and Ante Bolanča, and Zvonko Kusić
Department of Oncology and Nuclear Medicine, University Hospital Centre "Sestre Milosrdnice", Zagreb, Croatia.

OBJECTIVE The tyrosine kinase inhibitor (TKI) sunitinib malate is nowadays a standard first-line treatment option for patients with metastatic clear-cell renal cell carcinoma (mRCC). The aim of this study was to evaluate the incidence and clinical course of thyrotoxicosis in our cohort of patients treated with sunitinib. METHODS Medical records of all patients treated with first-line sunitinib for mRCC at our Institution between November 2008 and March 2014 were retrospectively reviewed. Thyroid function was assessed after every 2 cycles of therapy, during the 2 weeks off period. RESULTS Out of the 62 included patients, hypothyroidism has developed during therapy in 12 patients (19%) and it was preceded by thyrotoxicosis in 2 (3.2%). CONCLUSIONS Sunitinib-induced thyrotoxicosis (SIT), a not so rare entity, was followed by hypothyroidism. The patterns of occurrence and possible significance of SIT, as predictive marker of better treatment response to sunitinib, need to be validated in further studies.

UI MeSH Term Description Entries
D007211 Indoles Benzopyrroles with the nitrogen at the number one carbon adjacent to the benzyl portion, in contrast to ISOINDOLES which have the nitrogen away from the six-membered ring.
D007680 Kidney Neoplasms Tumors or cancers of the KIDNEY. Cancer of Kidney,Kidney Cancer,Renal Cancer,Cancer of the Kidney,Neoplasms, Kidney,Renal Neoplasms,Cancer, Kidney,Cancer, Renal,Cancers, Kidney,Cancers, Renal,Kidney Cancers,Kidney Neoplasm,Neoplasm, Kidney,Neoplasm, Renal,Neoplasms, Renal,Renal Cancers,Renal Neoplasm
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011758 Pyrroles Azoles of one NITROGEN and two double bonds that have aromatic chemical properties. Pyrrole
D002292 Carcinoma, Renal Cell A heterogeneous group of sporadic or hereditary carcinoma derived from cells of the KIDNEYS. There are several subtypes including the clear cells, the papillary, the chromophobe, the collecting duct, the spindle cells (sarcomatoid), or mixed cell-type carcinoma. Adenocarcinoma, Renal Cell,Carcinoma, Hypernephroid,Grawitz Tumor,Hypernephroma,Renal Carcinoma,Adenocarcinoma Of Kidney,Adenocarcinoma, Renal,Chromophil Renal Cell Carcinoma,Chromophobe Renal Cell Carcinoma,Clear Cell Renal Carcinoma,Clear Cell Renal Cell Carcinoma,Collecting Duct Carcinoma,Collecting Duct Carcinoma (Kidney),Collecting Duct Carcinoma of the Kidney,Nephroid Carcinoma,Papillary Renal Cell Carcinoma,Renal Cell Cancer,Renal Cell Carcinoma,Renal Cell Carcinoma, Papillary,Renal Collecting Duct Carcinoma,Sarcomatoid Renal Cell Carcinoma,Adenocarcinoma Of Kidneys,Adenocarcinomas, Renal Cell,Cancer, Renal Cell,Carcinoma, Collecting Duct,Carcinoma, Collecting Duct (Kidney),Carcinoma, Nephroid,Carcinoma, Renal,Carcinomas, Collecting Duct,Carcinomas, Collecting Duct (Kidney),Carcinomas, Renal Cell,Collecting Duct Carcinomas,Collecting Duct Carcinomas (Kidney),Hypernephroid Carcinoma,Hypernephroid Carcinomas,Hypernephromas,Kidney, Adenocarcinoma Of,Nephroid Carcinomas,Renal Adenocarcinoma,Renal Adenocarcinomas,Renal Carcinomas,Renal Cell Adenocarcinoma,Renal Cell Adenocarcinomas,Renal Cell Cancers,Renal Cell Carcinomas,Tumor, Grawitz
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077210 Sunitinib An indole and pyrrole derivative that inhibits VEGFR-2 and PDGFR BETA RECEPTOR TYROSINE KINASES. It is used as an antineoplastic agent for the treatment of GASTROINTESTINAL STROMAL TUMORS, and for treatment of advanced or metastatic RENAL CELL CARCINOMA. 5-(5-Fluoro-2-oxo-1,2-dihydroindolylidenemethyl)-2,4-dimethyl-1H-pyrrole-3-carboxylic acid (2-diethylaminoethyl)amide,SU 011248,SU 11248,SU-011248,SU-11248,SU011248,SU11248,Sunitinib Malate,Sutent
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective

Related Publications

Marijana Jazvić, and Marin Prpić, and Tomislav Jukić, and Jure Murgić, and Blanka Jakšić, and Davor Kust, and Angela Prgomet, and Ante Bolanča, and Zvonko Kusić
January 2009, Acta gastro-enterologica Belgica,
Marijana Jazvić, and Marin Prpić, and Tomislav Jukić, and Jure Murgić, and Blanka Jakšić, and Davor Kust, and Angela Prgomet, and Ante Bolanča, and Zvonko Kusić
December 2009, Journal of endocrinological investigation,
Marijana Jazvić, and Marin Prpić, and Tomislav Jukić, and Jure Murgić, and Blanka Jakšić, and Davor Kust, and Angela Prgomet, and Ante Bolanča, and Zvonko Kusić
April 2019, International journal of pediatric otorhinolaryngology,
Marijana Jazvić, and Marin Prpić, and Tomislav Jukić, and Jure Murgić, and Blanka Jakšić, and Davor Kust, and Angela Prgomet, and Ante Bolanča, and Zvonko Kusić
November 2023, International journal of cardiology,
Marijana Jazvić, and Marin Prpić, and Tomislav Jukić, and Jure Murgić, and Blanka Jakšić, and Davor Kust, and Angela Prgomet, and Ante Bolanča, and Zvonko Kusić
October 2016, Revue medicale de Liege,
Marijana Jazvić, and Marin Prpić, and Tomislav Jukić, and Jure Murgić, and Blanka Jakšić, and Davor Kust, and Angela Prgomet, and Ante Bolanča, and Zvonko Kusić
January 2015, Mediterranean journal of hematology and infectious diseases,
Marijana Jazvić, and Marin Prpić, and Tomislav Jukić, and Jure Murgić, and Blanka Jakšić, and Davor Kust, and Angela Prgomet, and Ante Bolanča, and Zvonko Kusić
August 2012, Skeletal radiology,
Marijana Jazvić, and Marin Prpić, and Tomislav Jukić, and Jure Murgić, and Blanka Jakšić, and Davor Kust, and Angela Prgomet, and Ante Bolanča, and Zvonko Kusić
October 2008, NDT plus,
Marijana Jazvić, and Marin Prpić, and Tomislav Jukić, and Jure Murgić, and Blanka Jakšić, and Davor Kust, and Angela Prgomet, and Ante Bolanča, and Zvonko Kusić
January 2022, Minerva anestesiologica,
Marijana Jazvić, and Marin Prpić, and Tomislav Jukić, and Jure Murgić, and Blanka Jakšić, and Davor Kust, and Angela Prgomet, and Ante Bolanča, and Zvonko Kusić
December 2014, International journal of biomedical science : IJBS,
Copied contents to your clipboard!